This cluster of papers focuses on the diagnosis, treatment, and risk factors associated with retinopathy of prematurity, a potentially blinding eye disorder that primarily affects premature infants. It covers topics such as screening examinations, use of intravitreal bevacizumab, neurodevelopmental outcomes, and the role of vascular endothelial growth factor and oxygen in the pathogenesis of the condition.